Restoril (temazepam) and Ambien (zolpidem) are not easily ranked as “stronger” or “weaker” because they work differently and excel at different aspects of sleep. Restoril is a broader-acting sedative that keeps you asleep longer, while Ambien is a more targeted drug that helps you fall asleep faster. Which one feels stronger depends on your specific sleep problem.
How Each Drug Works in the Brain
Both medications enhance the activity of GABA, the brain’s main calming chemical, but they do it in meaningfully different ways. Restoril is a benzodiazepine, which means it binds to a wide range of GABA receptor subtypes throughout the brain. This produces sedation, muscle relaxation, and anxiety reduction all at once.
Ambien takes a narrower approach. It has high affinity for just one specific receptor subtype (the alpha-1 subunit), which is the one most directly tied to inducing sleep. It has low or no affinity for the other subtypes that benzodiazepines hit. This is why Ambien produces sleepiness without as much muscle relaxation or anti-anxiety effect. For pure sleep initiation, that targeted action can feel potent. But for someone who lies awake due to anxiety, Restoril’s broader reach may feel more effective.
Speed, Duration, and Dosing
The biggest practical difference is how long each drug stays active. Ambien has an elimination half-life of roughly 2 to 3 hours, meaning it clears your system quickly. This makes it effective for falling asleep but less helpful if you wake at 3 a.m. The extended-release version (Ambien CR) stretches this effect, with initial doses of 6.25 mg for women and 6.25 to 12.5 mg for men, up to a maximum of 12.5 mg per night.
Restoril has a considerably longer half-life, typically 8 to 15 hours. It takes longer to reach full effect (usually 1 to 2 hours), but it sustains sedation through the night. Standard doses range from 7.5 mg to 30 mg. That longer duration is a double-edged sword: it helps with middle-of-the-night waking, but it also means you’re more likely to feel groggy the next morning.
Which Works Better for Insomnia
In a clinical trial directly comparing the two drugs for transient insomnia, neither zolpidem nor temazepam significantly reduced objective sleep latency (the time it takes to fall asleep) compared to placebo. That may sound surprising, but it reflects a consistent finding in sleep medicine: the subjective experience of these drugs, feeling like you slept better, often outpaces what sleep lab measurements show.
Where the drugs do separate is in how they affect sleep quality. Zolpidem in clinical-dose studies did not reduce deep sleep (stages 3 and 4) in healthy adults, though higher doses reduced REM sleep. Temazepam at 15 to 30 mg reduced deep sleep from about 8% to 5% of total sleep time in middle-aged adults with insomnia. Deep sleep is the most physically restorative stage, so this reduction matters. It’s one reason many sleep specialists consider Ambien to produce a more natural sleep pattern than Restoril.
Dependence and Duration of Use
Restoril carries a higher risk of physical dependence. As a full benzodiazepine, it activates the same receptor pathways as drugs like Valium and Ativan. Tolerance can develop within weeks, meaning you need higher doses for the same effect. Stopping abruptly after regular use can cause rebound insomnia, anxiety, and in severe cases, seizures.
Ambien’s dependence profile is somewhat more forgiving at recommended doses. Studies have shown no tolerance or rebound insomnia after 5 weeks of continuous nightly use at standard doses. Research also supports an “as needed” approach, with zolpidem taken 3 to 5 nights per week showing consistent effectiveness and safety over 8 weeks. That said, Ambien is not risk-free. Taking it above recommended doses or for extended periods can still lead to dependence, and it has a well-documented association with complex sleep behaviors like sleepwalking, sleep-eating, and even sleep-driving.
Risks for Older Adults
Both drugs appear on the American Geriatrics Society’s Beers Criteria, a list of medications considered potentially inappropriate for adults 65 and older. Both increase the risk of falls and fractures in this age group. For Ambien CR, the recommended dose for older adults is capped at 6.25 mg. Restoril’s long half-life makes it particularly problematic for seniors because the drug can still be active the next morning, impairing balance and reaction time well into the day.
Choosing Between Them
If your main problem is falling asleep, Ambien’s fast onset and targeted action make it the more common first choice, and its shorter duration means less next-day impairment. If you fall asleep fine but wake repeatedly through the night, Restoril’s longer action may be more useful, though at the cost of potential morning grogginess and a steeper dependence curve.
Neither drug is categorically “stronger.” Restoril hits more receptor types and lasts longer in your body, which can feel like a more powerful sedative experience overall. Ambien concentrates its effect on sleep-specific pathways, which makes it efficient at its narrow job. The right choice depends on whether your sleep problem is about falling asleep, staying asleep, or both, and how much you want to avoid next-day sedation and long-term dependence risk.